Literature DB >> 22079972

Differences in uveal melanomas between men and women from the British Isles.

B E Damato1, S E Coupland.   

Abstract

PURPOSE: The purpose of this study is to compare uveal melanomas (UMs) in men and women.
METHODS: The Liverpool Ocular Oncology Centre (LOOC) database was reviewed. Patients treated for UM at the LOOC between 1993 and 2010 were selected. Differences between sexes were identified using the χ (2)-test for categorical variables and the Mann-Whitney test for continuous variables.
RESULTS: The 3380 patients comprised 1685 women and 1695 men. The tumours were considered clinically to have arisen in choroid in 89.5%, ciliary body in 5.3%, and iris in 5.2%. Tumours in women were less likely to originate in choroid (87.2 vs 91.7%; P<0.001) and showed more circumferential spread in ciliary body (P<0.001) and iris (P=0.003). Tumours in men were more likely to extend to within 3 mm of optic disc or fovea (46.3 vs 39.0%, P<0.001), showing more extensive optic-disc involvement (P<0.001). The median largest basal tumour diameter was 12.2 mm in men and 11.9 mm in women (P=0.001). The tumour thickness had a median of 4.4 mm and 3.8 mm in men and women, respectively (P=0.015). The 180 ciliary body tumours occurred in 112 women and 68 men. In these, the prevalence of extraocular spread was higher in women (19.6 vs 8.8%; P=0.052). The 175 iris melanomas were more common in women than men (103 vs 72, respectively).
CONCLUSIONS: In men, UMs tend to be larger and more posterior than in women.

Entities:  

Mesh:

Year:  2011        PMID: 22079972      PMCID: PMC3272186          DOI: 10.1038/eye.2011.272

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

1.  Detection of uveal melanoma by optometrists in the United Kingdom.

Authors:  B Damato
Journal:  Ophthalmic Physiol Opt       Date:  2001-07       Impact factor: 3.117

2.  Rhegmatogenous retinal detachment after transscleral local resection of choroidal melanoma.

Authors:  Bertil Damato; Carl P Groenewald; Jim N McGalliard; David Wong
Journal:  Ophthalmology       Date:  2002-11       Impact factor: 12.079

3.  Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.

Authors:  Carol L Shields; Minoru Furuta; Archana Thangappan; Saya Nagori; Arman Mashayekhi; David R Lally; Cecilia C Kelly; Danielle S Rudich; Anand V Nagori; Oojwala A Wakade; Sonul Mehta; Lauren Forte; Andrew Long; Elaina F Dellacava; Bonnie Kaplan; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2009-08

4.  An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Meghan D Tuscan; J William Harbour
Journal:  J Mol Diagn       Date:  2010-04-22       Impact factor: 5.568

Review 5.  Eye retention after proton beam radiotherapy for uveal melanoma.

Authors:  Emmanuel Egger; Leonidas Zografos; Ann Schalenbourg; Donata Beati; Terence Böhringer; Line Chamot; Gudrun Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-15       Impact factor: 7.038

6.  Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival.

Authors:  Andrea G M Scholes; Bertil E Damato; Janice Nunn; Paul Hiscott; Ian Grierson; John K Field
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

Review 7.  Treatment of primary intraocular melanoma.

Authors:  Bertil Damato
Journal:  Expert Rev Anticancer Ther       Date:  2006-04       Impact factor: 4.512

8.  Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.

Authors:  Peter Isager; Niels Ehlers; Jens Overgaard
Journal:  Acta Ophthalmol Scand       Date:  2004-10

9.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

10.  Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients.

Authors:  Bertil Damato; Karin Lecuona
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

View more
  18 in total

1.  Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.

Authors:  B Damato
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

Review 2.  [Ocular melanomas : An update].

Authors:  H Kalirai; P L Müller; D Jaehne; S E Coupland
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

Review 3.  Disparities in Uveal Melanoma: Patient Characteristics.

Authors:  Erin E Nichols; Ann Richmond; Anthony B Daniels
Journal:  Semin Ophthalmol       Date:  2016-04-29       Impact factor: 1.975

4.  Ocular melanoma.

Authors:  Bertil E Damato; Sarah E Coupland
Journal:  Saudi J Ophthalmol       Date:  2012-04

5.  Possible role of standardized echography complementing ultrasound biomicroscopy in tumors of the anterior eye segment: a study in a series of 13 patients.

Authors:  B Kuzmanović Elabjer; M Bušić; D Miletić; M Bjeloš; N Vukojević; D Bosnar
Journal:  J Ultrasound       Date:  2018-05-17

Review 6.  Personalized treatment of uveal melanoma.

Authors:  B Damato; H Heimann
Journal:  Eye (Lond)       Date:  2012-11-23       Impact factor: 3.775

7.  Uveal Melanoma in Ireland.

Authors:  Caroline Baily; Valerie O'Neill; Mary Dunne; Moya Cunningham; Giuseppe Gullo; Susan Kennedy; Paul M Walsh; Sandra Deady; Noel Horgan
Journal:  Ocul Oncol Pathol       Date:  2018-09-13

8.  No Gender Differences in Long-Term Survival after Brachytherapy of 1,541 Patients with Uveal Melanoma.

Authors:  Gustav Stålhammar; Thonnie Rose See; Maria Filì; Stefan Seregard
Journal:  Ocul Oncol Pathol       Date:  2019-03-19

9.  The Patient's Experience of Ocular Melanoma in the US: A Survey of the Ocular Melanoma Foundation.

Authors:  Armin R Afshar; Michael Deiner; Grant Allen; Bertil E Damato
Journal:  Ocul Oncol Pathol       Date:  2018-02-08

Review 10.  Uveal Melanoma in Asians: A Review.

Authors:  Pradeep Manchegowda; Arun D Singh; Carol Shields; Swathi Kaliki; Parag Shah; Lingam Gopal; Pukhraj Rishi
Journal:  Ocul Oncol Pathol       Date:  2021-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.